These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31364536)

  • 1. Attrition during pre-ART and ART time periods among adolescents enrolled in Integrated HIV Care Programme in Myanmar, 2005-2017.
    Htun T; Kyaw KWY; Aung TK; Moe J; Mon AA; Tun CL; Mon O; Satyanarayana S; Oo HN
    Epidemiol Infect; 2019 Jan; 147():e206. PubMed ID: 31364536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis.
    Minn AC; Kyaw NTT; Aung TK; Mon OM; Htun T; Oo MM; Moe J; Mon AA; Satyanarayana S; Oo HN
    Glob Health Action; 2018; 11(1):1510593. PubMed ID: 30191749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alarming attrition rates among HIV-infected individuals in pre-antiretroviral therapy care in Myanmar, 2011-2014.
    Oo MM; Gupta V; Aung TK; Kyaw NT; Oo HN; Kumar AM
    Glob Health Action; 2016; 9():31280. PubMed ID: 27562473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to anti-retroviral therapy among people living with HIV enrolled into care in Myanmar: how prepared are we for 'test and treat'?
    Linn KZ; Shewade HD; Htet KKK; Maung TM; Hone S; Oo HN
    Glob Health Action; 2018; 11(1):1520473. PubMed ID: 30499382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV care.
    Lamb MR; Fayorsey R; Nuwagaba-Biribonwoha H; Viola V; Mutabazi V; Alwar T; Casalini C; Elul B
    AIDS; 2014 Feb; 28(4):559-68. PubMed ID: 24076661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis.
    Thida A; Tun ST; Zaw SK; Lover AA; Cavailler P; Chunn J; Aye MM; Par P; Naing KW; Zan KN; Shwe M; Kyaw TT; Waing ZH; Clevenbergh P
    PLoS One; 2014; 9(9):e108615. PubMed ID: 25268903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration.
    Kariminia A; Law M; Davies MA; Vinikoor M; Wools-Kaloustian K; Leroy V; Edmonds A; McGowan C; Vreeman R; Fairlie L; Ayaya S; Yotebieng M; Takassi E; Pinto J; Adedimeji A; Malateste K; Machado DM; Penazzato M; Hazra R; Sohn AH;
    J Int AIDS Soc; 2018 Dec; 21(12):e25215. PubMed ID: 30548817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with death and loss to follow-up in children on antiretroviral care in Mingalardon Specialist Hospital, Myanmar, 2006-2016.
    Kaung Nyunt KK; Han WW; Satyanarayana S; Isaakidis P; Hone S; Khaing AA; Nguyen Binh H; Oo HN
    PLoS One; 2018; 13(4):e0195435. PubMed ID: 29621302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes from the largest antiretroviral treatment program in Myanmar (Burma): a cohort analysis of retention after scale-up.
    Sabapathy K; Ford N; Chan KN; Kyaw MK; Elema R; Smithuis F; Floyd S
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):e53-62. PubMed ID: 22334069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants and rates of retention in HIV care among adolescents receiving antiretroviral therapy in Windhoek, Namibia: a baseline cohort analysis.
    Munyayi FK; van Wyk BE
    BMC Public Health; 2023 Mar; 23(1):458. PubMed ID: 36890540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of antiretroviral therapy in HIV-positive women ever enrolled into 'prevention of mother to child transmission' programme, Mandalay, Myanmar-a cohort study.
    Kyaw KWY; Satyanarayana S; Phyo KH; Kyaw NTT; Mon AA; Lwin TT; Aung TK; Oo MM; Aung ZZ; Htun T; Kham NSN; Mya T; Kumar AMV; Oo HN
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):474. PubMed ID: 30514239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are death and loss to follow-up still high in people living with HIV on ART after national scale-up and earlier treatment initiation? A large cohort study in government hospital-based setting, Myanmar: 2013-2016.
    Aung ZZ; Oo MM; Tripathy JP; Kyaw NTT; Hone S; Oo HN; Majumdar SS
    PLoS One; 2018; 13(9):e0204550. PubMed ID: 30252904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 17 year experience of attrition from care among HIV infected children in Nnewi South-East Nigeria.
    Onubogu CU; Ugochukwu EF
    BMC Infect Dis; 2021 May; 21(1):409. PubMed ID: 33941101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005-2015.
    Kyaw NT; Harries AD; Kumar AM; Oo MM; Kyaw KW; Win T; Aung TK; Min AC; Oo HN
    PLoS One; 2017; 12(2):e0171780. PubMed ID: 28182786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes of HIV-infected youth and young adolescents enrolled in HIV care in Kenya.
    Koech E; Teasdale CA; Wang C; Fayorsey R; Alwar T; Mukui IN; Hawken M; Abrams EJ
    AIDS; 2014 Nov; 28(18):2729-38. PubMed ID: 25493599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation and Operational Research: Evaluation of Swaziland's Hub-and-Spoke Model for Decentralizing Access to Antiretroviral Therapy Services.
    Auld AF; Kamiru H; Azih C; Baughman AL; Nuwagaba-Biribonwoha H; Ehrenkranz P; Agolory S; Sahabo R; Ellerbrock TV; Okello V; Bicego G
    J Acquir Immune Defic Syndr; 2015 May; 69(1):e1-12. PubMed ID: 25942465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.